Report Detail

Other Global AI-based Clinical Trials Solution Provider Market Growth (Status and Outlook) 2021-2026

  • RnM4330620
  • |
  • 12 July, 2021
  • |
  • Global
  • |
  • 122 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global AI-based Clinical Trials Solution Provider Market Size 2021-2026
    • 2.1.2 AI-based Clinical Trials Solution Provider Market Size CAGR by Region
  • 2.2 AI-based Clinical Trials Solution Provider Segment by Type
    • 2.2.1 Phase-I
    • 2.2.2 Phase-II
    • 2.2.3 Phase-III
  • 2.3 AI-based Clinical Trials Solution Provider Market Size by Type
    • 2.3.1 Global AI-based Clinical Trials Solution Provider Market Size Market Share by Type (2021-2026)
    • 2.3.2 Global AI-based Clinical Trials Solution Provider Market Size Growth Rate by Type (2021-2026)
  • 2.4 AI-based Clinical Trials Solution Provider Segment by Application
    • 2.4.1 Pharmaceutical Companies
    • 2.4.2 Academia
    • 2.4.3 Others
  • 2.5 AI-based Clinical Trials Solution Provider Market Size by Application
    • 2.5.1 Global AI-based Clinical Trials Solution Provider Market Size Market Share by Application (2021-2026)
    • 2.5.2 Global AI-based Clinical Trials Solution Provider Market Size Growth Rate by Application (2021-2026)

3 AI-based Clinical Trials Solution Provider Key Players

  • 3.1 Date of Key Players Enter into AI-based Clinical Trials Solution Provider
  • 3.2 Key Players AI-based Clinical Trials Solution Provider Product Offered
  • 3.3 Key Players AI-based Clinical Trials Solution Provider Funding/Investment Analysis
  • 3.4 Funding/Investment
    • 3.4.1 Funding/Investment by Regions
    • 3.4.2 Funding/Investment by End-Industry
  • 3.5 Key Players AI-based Clinical Trials Solution Provider Valuation & Market Capitalization
  • 3.6 Key Players Mergers & Acquisitions, Expansion Plans
  • 3.7 Market Ranking
  • 3.8 New Product/Technology Launches
  • 3.9 Partnerships, Agreements, and Collaborations
  • 3.10 Mergers and Acquisitions

4 AI-based Clinical Trials Solution Provider by Regions

  • 4.1 AI-based Clinical Trials Solution Provider Market Size by Regions (2021-2026)
  • 4.2 Americas AI-based Clinical Trials Solution Provider Market Size Growth (2021-2026)
  • 4.3 APAC AI-based Clinical Trials Solution Provider Market Size Growth (2021-2026)
  • 4.4 Europe AI-based Clinical Trials Solution Provider Market Size Growth (2021-2026)

5 Americas

  • 5.1 Americas AI-based Clinical Trials Solution Provider Market Size by Countries (2021-2026)
  • 5.2 Americas AI-based Clinical Trials Solution Provider Market Size by Type (2021-2026)
  • 5.3 Americas AI-based Clinical Trials Solution Provider Market Size by Application (2021-2026)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC AI-based Clinical Trials Solution Provider Market Size by Regions
  • 6.2 APAC AI-based Clinical Trials Solution Provider Market Size by Type (2021-2026)
  • 6.3 APAC AI-based Clinical Trials Solution Provider Market Size by Application (2021-2026)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe AI-based Clinical Trials Solution Provider by Countries (2021-2026)
  • 7.2 Europe AI-based Clinical Trials Solution Provider Market Size by Type (2021-2026)
  • 7.3 Europe AI-based Clinical Trials Solution Provider Market Size by Application (2021-2026)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Market Drivers, Challenges and Trends

  • 8.1 Market Drivers and Impact
    • 8.1.1 Growing Demand from Key Regions
    • 8.1.2 Growing Demand from Key Applications and Potential Industries
  • 8.2 Market Challenges and Impact
  • 8.3 Market Trends
  • 8.4 Market Ecosystem and Roles

9 Key Investors in AI-based Clinical Trials Solution Provider

  • 9.1 Company A
    • 9.1.1 Company A Company Details
    • 9.1.2 Company Description
    • 9.1.3 Companies Invested by Company A
    • 9.1.4 Company A Key Development and Market Layout
  • 9.2 Company B
    • 9.2.1 Company B Company Details
    • 9.2.2 Company Description
    • 9.2.3 Companies Invested by Company B
    • 9.2.4 Company B Key Development and Market Layout
  • 9.3 Company C
    • 9.3.1 Company C Company Details
    • 9.3.2 Company Description
    • 9.3.3 Companies Invested by Company C
    • 9.3.4 Company C Key Development and Market Layout
  • 9.4 Company D
  • 9.5 ……

10 Key Players Analysis

  • 10.1 Unlearn.AI, Inc.
    • 10.1.1 Unlearn.AI, Inc. Company Details
    • 10.1.2 Unlearn.AI, Inc. AI-based Clinical Trials Solution Provider Product Offered
    • 10.1.3 Unlearn.AI, Inc. AI-based Clinical Trials Solution Provider Market Size (2021 VS 2026)
    • 10.1.4 Unlearn.AI, Inc. Main Business Overview
    • 10.1.5 Unlearn.AI, Inc. News
  • 10.2 Saama Technologies
    • 10.2.1 Saama Technologies Company Details
    • 10.2.2 Saama Technologies AI-based Clinical Trials Solution Provider Product Offered
    • 10.2.3 Saama Technologies AI-based Clinical Trials Solution Provider Market Size (2021 VS 2026)
    • 10.2.4 Saama Technologies Main Business Overview
    • 10.2.5 Saama Technologies News
  • 10.3 Antidote Technologies, Inc.
    • 10.3.1 Antidote Technologies, Inc. Company Details
    • 10.3.2 Antidote Technologies, Inc. AI-based Clinical Trials Solution Provider Product Offered
    • 10.3.3 Antidote Technologies, Inc. AI-based Clinical Trials Solution Provider Market Size (2021 VS 2026)
    • 10.3.4 Antidote Technologies, Inc. Main Business Overview
    • 10.3.5 Antidote Technologies, Inc. News
  • 10.4 Phesi
    • 10.4.1 Phesi Company Details
    • 10.4.2 Phesi AI-based Clinical Trials Solution Provider Product Offered
    • 10.4.3 Phesi AI-based Clinical Trials Solution Provider Market Size (2021 VS 2026)
    • 10.4.4 Phesi Main Business Overview
    • 10.4.5 Phesi News
  • 10.5 Deep 6 AI
    • 10.5.1 Deep 6 AI Company Details
    • 10.5.2 Deep 6 AI AI-based Clinical Trials Solution Provider Product Offered
    • 10.5.3 Deep 6 AI AI-based Clinical Trials Solution Provider Market Size (2021 VS 2026)
    • 10.5.4 Deep 6 AI Main Business Overview
    • 10.5.5 Deep 6 AI News
  • 10.6 Innoplexus
    • 10.6.1 Innoplexus Company Details
    • 10.6.2 Innoplexus AI-based Clinical Trials Solution Provider Product Offered
    • 10.6.3 Innoplexus AI-based Clinical Trials Solution Provider Market Size (2021 VS 2026)
    • 10.6.4 Innoplexus Main Business Overview
    • 10.6.5 Innoplexus News
  • 10.7 Mendel.ai
    • 10.7.1 Mendel.ai Company Details
    • 10.7.2 Mendel.ai AI-based Clinical Trials Solution Provider Product Offered
    • 10.7.3 Mendel.ai AI-based Clinical Trials Solution Provider Market Size (2021 VS 2026)
    • 10.7.4 Mendel.ai Main Business Overview
    • 10.7.5 Mendel.ai News
  • 10.8 Intelligencia
    • 10.8.1 Intelligencia Company Details
    • 10.8.2 Intelligencia AI-based Clinical Trials Solution Provider Product Offered
    • 10.8.3 Intelligencia AI-based Clinical Trials Solution Provider Market Size (2021 VS 2026)
    • 10.8.4 Intelligencia Main Business Overview
    • 10.8.5 Intelligencia News
  • 10.9 Median Technologies
    • 10.9.1 Median Technologies Company Details
    • 10.9.2 Median Technologies AI-based Clinical Trials Solution Provider Product Offered
    • 10.9.3 Median Technologies AI-based Clinical Trials Solution Provider Market Size (2021 VS 2026)
    • 10.9.4 Median Technologies Main Business Overview
    • 10.9.5 Median Technologies News
  • 10.10 Symphony AI
    • 10.10.1 Symphony AI Company Details
    • 10.10.2 Symphony AI AI-based Clinical Trials Solution Provider Product Offered
    • 10.10.3 Symphony AI AI-based Clinical Trials Solution Provider Market Size (2021 VS 2026)
    • 10.10.4 Symphony AI Main Business Overview
    • 10.10.5 Symphony AI News
  • 10.11 BioAge Labs, Inc.
  • 10.12 AiCure, LLC
  • 10.13 CONSILX
  • 10.14 DEEP LENS AI
  • 10.15 Halo Health Systems
  • 10.16 Pharmaseal
  • 10.17 Ardigen
  • 10.18 Trials.Ai
  • 10.19 Koneksa Health
  • 10.20 Euretos
  • 10.21 BioSymetrics
  • 10.22 Google- Verily
  • 10.23 GNS Healthcare
  • 10.24 IBM Watson
  • 10.25 Exscientia

11 Research Findings and Conclusion

According to this study, over the next five years the AI-based Clinical Trials Solution Provider market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2026, from $ xx million in 2020.Specially this report presents the global revenue market share of key companies in AI-based Clinical Trials Solution Provider business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of AI-based Clinical Trials Solution Provider market by product type, application, key manufacturers and key regions and countries.

Segmentation by product type:
Phase-I
Phase-II
Phase-III

Segmentation by Application:
Pharmaceutical Companies
Academia
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Unlearn.AI, Inc.
Saama Technologies
Antidote Technologies, Inc.
Phesi
Deep 6 AI
Innoplexus
Mendel.ai
Intelligencia
Median Technologies
Symphony AI
BioAge Labs, Inc.
AiCure, LLC
CONSILX
DEEP LENS AI
Halo Health Systems
Pharmaseal
Ardigen
Trials.Ai
Koneksa Health
Euretos
BioSymetrics
Google- Verily
GNS Healthcare
IBM Watson
Exscientia


Summary:
Get latest Market Research Reports on AI-based Clinical Trials Solution Provider. Industry analysis & Market Report on AI-based Clinical Trials Solution Provider is a syndicated market report, published as Global AI-based Clinical Trials Solution Provider Market Growth (Status and Outlook) 2021-2026. It is complete Research Study and Industry Analysis of AI-based Clinical Trials Solution Provider market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,500.00
$7,000.00
2,544.50
5,089.00
2,968.00
5,936.00
386,645.00
773,290.00
260,575.00
521,150.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report